🇺🇸 FDA
Patent

US 12024505

Heterocyclic compounds useful as modulators of acetylcholine receptors

granted A61PA61P1/00A61P1/10

Quick answer

US patent 12024505 (Heterocyclic compounds useful as modulators of acetylcholine receptors) held by Takeda Pharmaceutical Company Limited expires Mon Jun 27 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Jul 02 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 27 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61P, A61P1/00, A61P1/10